Stem cell bioprinting for applications in regenerative medicine. Issue 1 (9th November 2016)

• Record Type: Journal Article
• Authors: Tricomi, Brad J.; Dias, Andrew D.; Corr, David T.
• Other Names: Sun Hui B. guestEditor.
• Is Part Of: Annals of the New York Academy of Sciences. Volume 1383:Issue 1(2016)
• Page Start: 115
• Page End: 124
• Publication Date: 2016-11-09
• Subjects: regenerative medicine -- tissue engineering -- biofabrication -- laser direct‐write -- inkjet bioprinting -- extrusion‐based bioprinting; Medical sciences -- Periodicals; Medicine -- Periodicals; Science -- Periodicals; 610
• DOI: 10.1111/nyas.13266
• Languages: English
• ISSNs: 0077-8923

Abstract

Abstract : Many regenerative medicine applications seek to harness the biologic power of stem cells in architecturally complex scaffolds or microenvironments. Traditional tissue engineering methods cannot create such intricate structures, nor can they precisely control cellular position or spatial distribution. These limitations have spurred advances in the field of bioprinting, aimed to satisfy these structural and compositional demands. Bioprinting can be defined as the programmed deposition of cells or other biologics, often with accompanying biomaterials. In this concise review, we focus on recent advances in stem cell bioprinting, including performance, utility, and applications in regenerative medicine. More specifically, this review explores the capability of bioprinting to direct stem cell fate, engineer tissue(s), and create functional vascular networks. Furthermore, the unique challenges and concerns related to bioprinting living stem cells, such as viability and maintaining multi‐ or pluripotency, are discussed. The regenerative capacity of stem cells, when combined with the structural/compositional control afforded by bioprinting, provides a unique and powerful tool to address the complex demands of tissue engineering and regenerative medicine applications.